纳米颗粒的应用作为先进的药物输送系统在减轻COPD中的应用
Victoria Jessamine1, Samir Mehndiratta1,2, Gabriele De Rubis1,2
1Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia.
Heliyon
|February 15, 2024
概括
纳米粒子为慢性阻塞性肺病 (COPD) 提供了先进的治疗方法,克服了当前治疗方法的局限性. 本综述探讨了纳米颗粒对COPD管理的好处,包括减少副作用和更少的剂量.
科学领域:
- 肺部医学 肺部医学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及炎症,自由基损伤和呼吸道阻塞.
- 目前的COPD治疗有局限性,包括不良的全身效应,频繁的剂量和无法阻止疾病的进展.
研究的目的:
- 审查传统COPD疗法的好处和局限性.
- 为基于纳米粒子的 COPD 治疗系统的先进应用提供洞察力.
主要方法:
- 对传统的COPD管理策略的文献综述.
- 对药物输送相关的纳米粒子属性的探索.
- 基于NP的系统对COPD治疗潜力的分析.
主要成果:
- 传统的COPD药物表现出全身副作用和坚持挑战.
- 纳米颗粒显示出高特异性,生物相容性和生物可用性用于COPD治疗.
- 基于NP的输送系统可以减少剂量和减少副作用.
结论:
- 基于纳米粒子的药物输送系统为COPD提供了一个有前途的治疗方法.
- 这些先进的系统有可能提高治疗效率和患者的坚持,同时最大限度地减少不良影响.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
COPD: Pathogenesis and Clinical Features
273
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
273
Drug Delivery: Miscellaneous Routes
339
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
339
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


